Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasms × Cryosurgery × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 7 Pain 3 Lung Neoplasms 2 Colorectal Neoplasms 2 Bone Neoplasms 2 Neoplasms 1 Menorrhagia 1 Leiomyoma 1 Kidney Neoplasms 1 Keratosis, Actinic 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Barrett Esophagus 1

Interventions

pembrolizumab 109 Paclitaxel 85 Gemcitabine 82 Carboplatin 72 Nivolumab 55 Docetaxel 54 Bevacizumab 53 Cisplatin 44 Pemetrexed 42 Fluorouracil 40 Cyclophosphamide 38 Cetuximab 31 Capecitabine 31 Leucovorin 30 venetoclax 29 Irinotecan 29 trametinib 28 atezolizumab 28 Sorafenib 28 Erlotinib Hydrochloride 26 Dexamethasone 25 130-nm albumin-bound paclitaxel 25 Drug Therapy 24 Ipilimumab 23 Epoetin Alfa 23 Doxorubicin 22 Oxaliplatin 20 Prednisone 19 Lapatinib 19 dabrafenib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01307501 2021-07-19

ECLIPSE

Boston Scientific Corporation

Phase NA Completed

40 enrolled 19 charts

Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡